Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI
Key claim: Sarcopenia and muscle loss represent critical prognostic factors that warrant systematic screening in chronic heart failure and pre-TAVI patients to guide management.
Abstract
The main objective was to assess the prevalence of sarcopenia in chronic heart failure patients and in patients before the trans aortic valvular implantation.
The loss of muscle mass in chronic heart failure patients is a prognostic factor for sarcopenia. The purpose was to identify in these patients signs of sarcopenia for a better management.
Why this matters
Sarcopenia and muscle loss represent critical prognostic factors that warrant systematic screening in chronic heart failure and pre-TAVI patients to guide management.